First-in-human study of CJRB-101, a live biotherapeutic product in combination with pembrolizumab in selected types of advanced or metastatic cancer.

Authors: Jii Bum Lee, Jin Seok Ahn, Misako Nagasaka, Diwakar Davar, Dong Kwon Kim, Ga-Hyun Shin, Soeun Kim, Eunchong Yang, Hyun Kim, Arim Min, Bo-Eun Kwon, Junwon Yang, Hyun-Seok Oh, Min Hee Hong, Sun Min Lim, Byoung Chul Cho

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.8547

Source: Full article

---

Abstract

8547